ReoPro® (abciximab) – Drug Shortage
October 9, 2018 - The drug shortage of Janssen Biotech’s ReoPro (abciximab) is ongoing. Reopro has been unavailable for at least 90 days due to a long-term shortage of an ingredient from a third party manufacturer. Janssen Biotech does not have an estimated time frame as to when the shortage will resolve.
Top